Skip to main content
. 2021 Nov 26;28(3):351–361. doi: 10.3350/cmh.2021.0281

Figure 2.

Figure 2.

AUROCs value of HCC prediction models for CHB patients. This graph shows the AUROC value predicting 5-year HCC prediction in CHB patients. HCC, hepatocellular carcinoma; CHB, chronic hepatitis B; NA, nucleos(t)ide analogues; AUROC, area under the receiver operating characteristic; LS, liver stiffness; LSM, LS measurement; LSPS, LSM-spleen diameter to platelet ratio score; RWS, real-world risk.